Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TCPOBOP is a constitutive androstane receptor agonist that induces robust hepatocyte proliferation and hepatomegaly. TCPOBOP decreases Fas-induced murine liver injury by altering Bcl-2 proteins.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 10,500 | |||
10 mg | 在庫あり | ¥ 16,000 | |||
25 mg | 在庫あり | ¥ 29,000 | |||
50 mg | 在庫あり | ¥ 47,500 | |||
100 mg | 在庫あり | ¥ 75,500 | |||
200 mg | 在庫あり | ¥ 113,000 |
説明 | TCPOBOP is a constitutive androstane receptor agonist that induces robust hepatocyte proliferation and hepatomegaly. TCPOBOP decreases Fas-induced murine liver injury by altering Bcl-2 proteins. |
In vivo | TCPOBOP (p.o.; 3 mg/kg; 1-5 days) obviously enhances Liver weight to body weight in LW/BW ratio at 48 hours [1]. |
分子量 | 402.06 |
分子式 | C16H8Cl4N2O2 |
CAS No. | 76150-91-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (62.18 mM), Sonication and heating to 50℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TCPOBOP 76150-91-9 Apoptosis BCL inhibit Bcl-2 Family Inhibitor inhibitor